Effects of the novel phosphodiesterase type 5 inhibitor sildenafil, on methacholine-induced relaxation of rabbit isolated corpus cavernosum

被引：0
|
作者：
Tang, K [1 ]
Turner, LA [1 ]
Ballard, SA [1 ]
Naylor, AM [1 ]
机构：
[1] PFIZER LTD,CENT RES,DEPT DISCOVERY BIOL,SANDWICH CT13 9NJ,KENT,ENGLAND
来源：
BRITISH JOURNAL OF PHARMACOLOGY | 1996年 / 118卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：P154 / P154
页数：1
相关论文
共 49 条
  • [41] Sildenafil, a Type-5 Phosphodiesterase Inhibitor, Fails to Reverse Myeloid-Derived Suppressor Cell-Mediated T Cell Suppression in Cells Isolated From Tuberculosis Patients
    Leukes, Vinzeigh N.
    Malherbe, Stephanus T.
    Hiemstra, Andriette
    Kotze, Leigh A.
    Roos, Kelly
    Keyser, Alana
    De Swardt, Dalene
    Gutschmidt, Andrea
    Walzl, Gerhard
    du Plessis, Nelita
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [42] Vardenafil:: a novel type 5 phosphodiesterase inhibitor reduces myocardial infarct size following ischemia/reperfusion injury via opening of mitochondrial KATP channels in rabbit
    Salloum, F
    Ockaili, R
    Wittkamp, M
    Marwaha, VR
    Kukreja, RC
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2004, 37 (01) : 209 - 209
  • [43] Acrosome integrity and agonist-induced acrosome reaction rate after stimulation by varying concentrations of a specific inhibitor of cGMP phosphodiesterase type-5 (sildenafil) in normozoospermic specimens.
    Esteves, S
    Glina, S
    Verza, S
    Wonchockier, R
    Corrêa, N
    FERTILITY AND STERILITY, 2005, 84 : S225 - S225
  • [44] Combined Effects of the Phosphodiesterase Type 4 (PDE4) Inhibitor, Roflumilast, and the PDE5 Inhibitor, Tadalafil, in Allergen-Induced Airway Hyperresponsiveness (AHR).
    Takeda, K.
    Shiraishi, Y.
    Domenico, J.
    Loader, J. E.
    Sanjar, S.
    Lucas, J. J.
    Gelfand, E. W.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [45] Acute effects of a single dose of phosphodiesterase type 5 inhibitor (Sildenafil) on systemic arterial blood pressure during exercise and 24-hour ambulatory blood pressure monitoring in heart transplant recipients
    Guimaraes, G. V.
    d'Avila, V. M.
    Pires, P.
    Bacal, F.
    Stolf, N.
    Bocchi, E.
    TRANSPLANTATION PROCEEDINGS, 2007, 39 (10) : 3142 - 3149
  • [46] THE ERECTOGENIC EFFECTS OF CKD-533, A NEW POTENT AND SELECTIVE PHOSPHODIESTERASE TYPE5 INHIBITOR, IN ERECTILE DYSFUNCTION INDUCED BY SPINAL CORD INJURY ON RABBITS
    Ha, N.
    Jung, J. Y.
    Hwang, I. C.
    Park, J. H.
    Kim, S. K.
    Kim, S. J.
    Kim, H. J.
    Yu, H. S.
    Kim, Y. M.
    Kim, D. H.
    Lee, S. S.
    JOURNAL OF SEXUAL MEDICINE, 2010, 7 : 201 - 201
  • [47] The effects of single versus combined therapy using LIM-kinase 2 inhibitor and type 5 phosphodiesterase inhibitor on erectile function in a rat model of cavernous nerve injury-induced erectile dysfunction
    Cho, Min Chul
    Lee, Junghoon
    Park, Juhyun
    Oh, Sohee
    Chai, Ji Sun
    Son, Hwancheol
    Paick, Jae-Seung
    Kim, Soo Woong
    ASIAN JOURNAL OF ANDROLOGY, 2019, 21 (05) : 493 - 500
  • [48] Beneficial effects of a phosphodiesterase type 5 inhibitor (sildenafil) on exercise, neurohormonal activation, and erectile dysfunction in patients with congestive heart failure-α double-blind placebo-controlled cross-over ramdomized study
    Bocchi, EA
    Guimarâes, G
    Bellotti, G
    Ramires, JAF
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (02) : 163A - 163A
  • [49] Effects of a phosphodiesterase type 5 inhibitor (sildenafil) evaluated by 24-hour blood pressure monitoring and exercise capacity in heart transplanted patients. A double-blind, placebo-controlled, cross-over, randomized study. Preliminary results
    Guimaraes, G. V.
    d'Avila, V. M.
    Pires, P. V.
    Cruz, F. D.
    Stolf, N. A.
    Chizzola, P. R.
    Bocchi, E. A.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2005, 24 (02): : S115 - S115
12345